These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 23672025)
1. [Design, synthesis and cholinesterase inhibitory activity of quinoline-polyamine conjugates]. Luo W; Huang K; Zhang Z; Hong C; Wang CJ Yao Xue Xue Bao; 2013 Feb; 48(2):269-75. PubMed ID: 23672025 [TBL] [Abstract][Full Text] [Related]
2. [Design, synthesis and evaluation of tacrine-methoxybenzene hybrids as cholinesterases inhibitors]. Luo W; Zhao YM; Zhang Z; Su YB; Wang CJ Yao Xue Xue Bao; 2012 Jul; 47(7):916-21. PubMed ID: 22993857 [TBL] [Abstract][Full Text] [Related]
3. Novel aromatic-polyamine conjugates as cholinesterase inhibitors with notable selectivity toward butyrylcholinesterase. Hong C; Luo W; Yao D; Su YB; Zhang X; Tian RG; Wang CJ Bioorg Med Chem; 2014 Jun; 22(12):3213-9. PubMed ID: 24794747 [TBL] [Abstract][Full Text] [Related]
4. [Design, synthesis and evaluation of bis-nicotine derivatives as inhibitors of cholinesterases and beta-amyloid aggregation]. Luo W; Zhao YM; Tian RG; Su YB; Hong C Yao Xue Xue Bao; 2013 Nov; 48(11):1671-6. PubMed ID: 24475704 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and acetylcholinesterase and butyrylcholinesterase inhibitory activities of 7-alkoxyl substituted indolizinoquinoline-5,12-dione derivatives. Wu ZP; Wu XW; Shen T; Li YP; Cheng X; Gu LQ; Huang ZS; An LK Arch Pharm (Weinheim); 2012 Mar; 345(3):175-84. PubMed ID: 21989769 [TBL] [Abstract][Full Text] [Related]
6. Design and synthesis of novel anti-Alzheimer's agents: Acridine-chromenone and quinoline-chromenone hybrids. Najafi Z; Saeedi M; Mahdavi M; Sabourian R; Khanavi M; Tehrani MB; Moghadam FH; Edraki N; Karimpor-Razkenari E; Sharifzadeh M; Foroumadi A; Shafiee A; Akbarzadeh T Bioorg Chem; 2016 Aug; 67():84-94. PubMed ID: 27289559 [TBL] [Abstract][Full Text] [Related]
7. Design and synthesis of some new carboxamide and propanamide derivatives bearing phenylpyridazine as a core ring and the investigation of their inhibitory potential on in-vitro acetylcholinesterase and butyrylcholinesterase. Kilic B; Gulcan HO; Aksakal F; Ercetin T; Oruklu N; Umit Bagriacik E; Dogruer DS Bioorg Chem; 2018 Sep; 79():235-249. PubMed ID: 29775949 [TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and evaluation of novel 7-aminoalkyl-substituted flavonoid derivatives with improved cholinesterase inhibitory activities. Luo W; Chen Y; Wang T; Hong C; Chang LP; Chang CC; Yang YC; Xie SQ; Wang CJ Bioorg Med Chem; 2016 Feb; 24(4):672-80. PubMed ID: 26752094 [TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, biological evaluation, and molecular modeling studies of quinoline-ferulic acid hybrids as cholinesterase inhibitors. Mo J; Yang H; Chen T; Li Q; Lin H; Feng F; Liu W; Qu W; Guo Q; Chi H; Chen Y; Sun H Bioorg Chem; 2019 Dec; 93():103310. PubMed ID: 31586704 [TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and biological evaluation of benzofuran appended benzothiazepine derivatives as inhibitors of butyrylcholinesterase and antimicrobial agents. Mostofi M; Mohammadi Ziarani G; Lashgari N Bioorg Med Chem; 2018 Jul; 26(12):3076-3095. PubMed ID: 29866481 [TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and biological evaluation of 3,4-dihydro-2(1H)-quinoline-O-alkylamine derivatives as new multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimer's disease. Sang Z; Pan W; Wang K; Ma Q; Yu L; Liu W Bioorg Med Chem; 2017 Jun; 25(12):3006-3017. PubMed ID: 28487125 [TBL] [Abstract][Full Text] [Related]
12. Quinoline containing chalcone derivatives as cholinesterase inhibitors and their in silico modeling studies. Shah MS; Najam-Ul-Haq M; Shah HS; Farooq Rizvi SU; Iqbal J Comput Biol Chem; 2018 Oct; 76():310-317. PubMed ID: 30142564 [TBL] [Abstract][Full Text] [Related]
13. Synthesis, biological evaluation, and molecular modeling of berberine derivatives as potent acetylcholinesterase inhibitors. Huang L; Shi A; He F; Li X Bioorg Med Chem; 2010 Feb; 18(3):1244-51. PubMed ID: 20056426 [TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and evaluation of novel 4-dimethylamine flavonoid derivatives as potential multi-functional anti-Alzheimer agents. Luo W; Su YB; Hong C; Tian RG; Su LP; Wang YQ; Li Y; Yue JJ; Wang CJ Bioorg Med Chem; 2013 Dec; 21(23):7275-82. PubMed ID: 24148835 [TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and evaluation of difunctionalized 4-hydroxybenzaldehyde derivatives as novel cholinesterase inhibitors. Yu L; Cao R; Yi W; Yan Q; Chen Z; Ma L; Song H Chem Pharm Bull (Tokyo); 2010 Sep; 58(9):1216-20. PubMed ID: 20823602 [TBL] [Abstract][Full Text] [Related]
16. Design and Synthesis of Selective Acetylcholinesterase Inhibitors: Arylisoxazole-Phenylpiperazine Derivatives. Saeedi M; Mohtadi-Haghighi D; Mirfazli SS; Mahdavi M; Hariri R; Lotfian H; Edraki N; Iraji A; Firuzi O; Akbarzadeh T Chem Biodivers; 2019 Feb; 16(2):e1800433. PubMed ID: 30460743 [TBL] [Abstract][Full Text] [Related]
17. Synthesis of novel 5-(aroylhydrazinocarbonyl)escitalopram as cholinesterase inhibitors. Nisa MU; Munawar MA; Iqbal A; Ahmed A; Ashraf M; Gardener QA; Khan MA Eur J Med Chem; 2017 Sep; 138():396-406. PubMed ID: 28688279 [TBL] [Abstract][Full Text] [Related]
18. Structure-activity relationships of acetylcholinesterase noncovalent inhibitors based on a polyamine backbone. 4. Further investigation on the inner spacer. Tumiatti V; Milelli A; Minarini A; Rosini M; Bolognesi ML; Micco M; Andrisano V; Bartolini M; Mancini F; Recanatini M; Cavalli A; Melchiorre C J Med Chem; 2008 Nov; 51(22):7308-12. PubMed ID: 18954037 [TBL] [Abstract][Full Text] [Related]